NCT05515978 2025-12-04
PragMet
University of Colorado, Denver
Phase EARLY_PHASE1 Recruiting
Clinical Trials
10 trialsNCT05929495 2025-07-25
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
University of Milano Bicocca
Phase 2 Recruiting
NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown
NCT03017833 2023-10-04
Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01528046 2023-01-13
Metformin in Children With Relapsed or Refractory Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04780854 2021-07-28
Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Cairo University
Phase 2 Unknown
NCT03086733 2020-08-19
Metcore
University Health Network, Toronto
Phase 2 Completed
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT03874000 2019-03-19
SMART
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT01442870 2017-05-09
Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy
Tufts Medical Center
Phase 1 Completed